Authors
Loading...
Retrospective analysis evaluates dabrafenib or trametinib in pediatric LCH, suggesting promising outcomes and safety.
Ouyang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: